|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yuan X, Wang LU, Xue J, Li LI and Zhang J:
Endocrine MPA enhances the effects of TAC chemotherapy on
improvement of prognosis and increase in long-term survival rates
for patients with endometrial cancer. Oncol Lett. 10:1902–1906.
2015.PubMed/NCBI
|
|
3
|
Bernardo GM and Keri RA: FOXA1: A
transcription factor with parallel functions in development and
cancer. Biosci Rep. 32:113–130. 2012. View Article : Google Scholar
|
|
4
|
Wang J, Bao W, Qiu M, Liao Y, Che Q, Yang
T, He X, Qiu H and Wan X: Forkhead-box A1 suppresses the
progression of endometrial cancer via crosstalk with estrogen
receptor α. Oncol Rep. 31:1225–1234. 2014.PubMed/NCBI
|
|
5
|
Kuilman T, Michaloglou C, Mooi WJ and
Peeper DS: The essence of senescence. Genes Dev. 24:2463–2479.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Falandry C, Bonnefoy M, Freyer G and
Gilson E: Biology of cancer and aging: A complex association with
cellular senescence. J Clin Oncol. 32:2604–2610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
López-Otín C, Blasco MA, Partridge L,
Serrano M and Kroemer G: The hallmarks of aging. Cell.
153:1194–1217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kool J, Uren AG, Martins CP, Sie D, de
Ridder J, Turner G, van Uitert M, Matentzoglu K, Lagcher W,
Krimpenfort P, et al: Insertional mutagenesis in mice deficient for
p15Ink4b, p16Ink4a, p21Cip1, and
p27Kip1 reveals cancer gene interactions and
correlations with tumor phenotypes. Cancer Res. 70:520–531. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McLaughlin-Drubin ME, Park D and Munger K:
Tumor suppressor p16INK4A is necessary for survival of
cervical carcinoma cell lines. Proc Natl Acad Sci USA.
110:16175–16180. 2013. View Article : Google Scholar
|
|
10
|
Li Q, Zhang Y, Fu J, Han L, Xue L, Lv C,
Wang P, Li G and Tong T: FOXA1 mediates p16INK4a
activation during cellular senescence. EMBO J. 32:858–873. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Collado M, Blasco MA and Serrano M:
Cellular senescence in cancer and aging. Cell. 130:223–233. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Niino YS, Irie T, Takaishi M, Hosono T,
Huh N, Tachikawa T and Kuroki T: PKCtheta II, a new isoform of
protein kinase C specifically expressed in the seminiferous tubules
of mouse testis. J Biol Chem. 276:36711–36717. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Abe Y, Ijichi N, Ikeda K, Kayano H,
Horie-Inoue K, Takeda S and Inoue S: Forkhead box transcription
factor, forkhead box A1, shows negative association with lymph node
status in endometrial cancer, and represses cell proliferation and
migration of endometrial cancer cells. Cancer Sci. 103:806–812.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu X, Lu Z, Qiang W, Vidimar V, Kong B,
Kim JJ and Wei JJ: Inactivation of AKT induces cellular senescence
in uterine leiomyoma. Endocrinology. 155:1510–1519. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chaussade C, Rewcastle GW, Kendall JD,
Denny WA, Cho K, Grønning LM, Chong ML, Anagnostou SH, Jackson SP,
Daniele N, et al: Evidence for functional redundancy of class IA
PI3K isoforms in insulin signalling. Biochem J. 404:449–458. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Semba S, Itoh N, Ito M, Harada M and
Yamakawa M: The in vitro and in vivo effects of
2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific
inhibitor of phosphatidylinositol 3′-kinase, in human colon cancer
cells. Clin Cancer Res. 8:1957–1963. 2002.PubMed/NCBI
|
|
18
|
Tangen IL, Krakstad C, Halle MK, Werner
HM, Oyan AM, Kusonmano K, Petersen K, Kalland KH, Akslen LA, Trovik
J, et al: Switch in FOXA1 status associates with endometrial cancer
progression. PLoS One. 9:e980692014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qiu M, Bao W, Wang J, Yang T, He X, Liao Y
and Wan X: FOXA1 promotes tumor cell proliferation through AR
involving the Notch pathway in endometrial cancer. BMC Cancer.
14:782014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y and Tong T: FOXA1 antagonizes
EZH2-mediated CDKN2A repression in carcinogenesis. Biochem Biophys
Res Commun. 453:172–178. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hirai H, Tani T and Kikyo N: Structure and
functions of powerful transactivators: VP16, MyoD and FoxA. Int J
Dev Biol. 54:1589–1596. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Serrano M: Unraveling the links between
cancer and aging. Carcinogenesis. 37:1072016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moritani S, Ichihara S, Hasegawa M,
Iwakoshi A, Murakami S, Sato T, Okamoto T, Mori Y, Kuhara H and
Silverberg SG: Stromal p16 expression differentiates endometrial
polyp from endometrial hyperplasia. Virchows Arch. 461:141–148.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kennedy AL, Morton JP, Manoharan I, Nelson
DM, Jamieson NB, Pawlikowski JS, McBryan T, Doyle B, McKay C, Oien
KA, et al: Activation of the PIK3CA/AKT pathway suppresses
senescence induced by an activated RAS oncogene to promote
tumorigenesis. Mol Cell. 42:36–49. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Goswami A, Shah BA, Kumar A, Rizvi MA,
Kumar S, Bhushan S, Malik FA, Batra N, Joshi A and Singh J:
Antiproliferative potential of a novel parthenin analog P16 as
evident by apoptosis accompanied by down-regulation of PI3K/AKT and
ERK pathways in human acute lymphoblastic leukemia MOLT-4 cells.
Chem Biol Interact. 222C:60–67. 2014. View Article : Google Scholar
|
|
26
|
Kipkeew F, Kirsch M, Klein D, Wuelling M,
Winterhager E and Gellhaus A: CCN1 (CYR61) and CCN3 (NOV) signaling
drives human trophoblast cells into senescence and stimulates
migration properties. Cell Adh Migr. 10:163–178. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu J, Chen C, Hu X, Cai X, Guan Y, Hu H,
Wang Q, Chen X, Cai B and Jing X: Suppressing cyclooxygenase-2
prevents nonalcoholic steatohepatitis and inhibits apoptosis of
hepatocytes that are involved in the Akt/p53 signal pathway.
Biochem Biophys Res Commun. 469:1034–1040. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ren H, Zhang P, Tang Y, Wu M and Zhang W:
Forkhead box protein A1 is a prognostic predictor and promotes
tumor growth of gastric cancer. Onco Targets Ther. 8:3029–3039.
2015.PubMed/NCBI
|
|
29
|
Song Y, Washington MK and Crawford HC:
Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal
transition in pancreatic cancer. Cancer Res. 70:2115–2125. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tachi K, Shiraishi A, Bando H, Yamashita
T, Tsuboi I, Kato T, Hara H and Ohneda O: FOXA1 expression affects
the proliferation activity of luminal breast cancer stem cell
populations. Cancer Sci. 107:281–289. 2016. View Article : Google Scholar :
|
|
31
|
Gong C, Fujino K, Monteiro LJ, Gomes AR,
Drost R, Davidson-Smith H, Takeda S, Khoo US, Jonkers J, Sproul D,
et al: FOXA1 repression is associated with loss of BRCA1 and
increased promoter methylation and chromatin silencing in breast
cancer. Oncogene. 34:5012–5024. 2015. View Article : Google Scholar :
|
